Clinical Trial Update: Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial compared two oral formulations of artemether-lumefantrine for treating uncomplicated Plasmodium falciparum malaria; the study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria Falciparum

Drugs mentioned

• artemether-lumefantrine (oral formulation A) (artemether-lumefantrine)
• artemether-lumefantrine (oral formulation B) (artemether-lumefantrine)

Snippet

Sponsor: Dafra Pharma | Conditions: Malaria, Falciparum | Phase 4 | Status: COMPLETED